Thomas Muley
Heidelberg University · 490 works · 21,903 citations · h-index 64
Top works
- Comprehensive genomic characterization of squamous cell lung cancers
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- Comprehensive genomic profiles of small cell lung cancer
- The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival
- SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells
- Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients
- Prognostic Impact of Intra-alveolar Tumor Spread in Pulmonary Adenocarcinoma
- Targeting RET in Patients With RET -Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
- Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma
- Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
- The Integrated Genomic Landscape of Thymic Epithelial Tumors
- An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer
- Nodal Involvement at the Time of Pulmonary Metastasectomy: Experiences in 245 Patients
- Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes
- Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls
- Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-Analysis
- Adrenalectomy for solitary adrenal metastases from non-small cell lung cancer
- Prognostic assessment after surgical resection for non-small cell lung cancer: Experiences in 2083 patients
- SMARCA4 and SMARCA2 deficiency in non–small cell lung cancer: immunohistochemical survey of 316 consecutive specimens
- EGFR,KRAS,BRAFandALKgene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype